# BIOA (Bioage Labs, Inc.) - SEC EDGAR Financial Statements

> Bioage Labs, Inc. reported $8.60M in revenue and a net loss of $107.8M for the trailing twelve months ended September 30, 2026 (down 85.5% year over year), with a -1401.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/BIOA
- Markdown: https://convexityos.com/fundamentals/BIOA.md
- SEC CIK: 0001709941
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:43 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001709941&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $8.60M | -85.5% YoY |
| Operating Income | TTM | -$120.5M | -1401.8% margin |
| Net Income | TTM | -$107.8M | -1253.6% net margin |
| Diluted EPS | TTM | -$2.35 | Split-adjusted |
| Free Cash Flow | TTM | -$103.0M | -1197.8% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $283.6M | Total debt: $2.73M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $8.99M | $0 | -- |
| Research & Development | $73.97M | $59.04M | $33.89M |
| Total Operating Expenses | $101.8M | $78.19M | $48.40M |
| **Operating Income** | -$92.78M | -$78.19M | -$48.40M |
| **EBITDA** | -$92.58M | -$77.99M | -$48.20M |
| Interest Expense | $697K | $2.37M | $7.79M |
| Income Before Tax | -$80.61M | -$71.11M | -$63.85M |
| Income Tax Expense | $0 | $0 | $0 |
| **Net Income** | -$80.61M | -$71.11M | -$63.85M |
| Basic EPS | -$2.24 | -$6.63 | -$38.17 |
| **Diluted EPS** | -$2.24 | -$6.63 | -$38.17 |
| Basic Shares Outstanding | 35.9M | 10.7M | 1.7M |
| Diluted Shares Outstanding | 35.9M | 10.7M | 1.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $298K | $2.45M | $2.77M | $3.08M | $2.05M | $2.41M | $1.45M | -- |
| Research & Development | $30.23M | $24.36M | $20.41M | $24.50M | $18.51M | $19.84M | $11.11M | $19.23M |
| Total Operating Expenses | $37.71M | $31.78M | $28.15M | $31.50M | $25.19M | $27.18M | $17.90M | $25.36M |
| **Operating Income** | -$37.41M | -$29.33M | -$25.38M | -$28.42M | -$23.14M | -$24.77M | -$16.45M | -$25.36M |
| Interest Expense | $0 | $1.0K | $39K | $92K | $149K | $201K | $255K | $319K |
| **Net Income** | -$33.50M | -$26.10M | -$22.25M | -$25.94M | -$20.17M | -$21.56M | -$12.93M | -$21.13M |
| Basic EPS | -$0.73 | -$0.58 | -$0.52 | -- | -$0.56 | -$0.60 | -$0.36 | -- |
| **Diluted EPS** | -$0.73 | -$0.58 | -$0.52 | -- | -$0.56 | -$0.60 | -$0.36 | -- |
| Basic Shares Outstanding | 45.9M | 44.8M | 42.5M | -- | 35.9M | 35.9M | 35.9M | -- |
| Diluted Shares Outstanding | 45.9M | 44.8M | 42.5M | -- | 35.9M | 35.9M | 35.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $188.9M | $354.3M | $21.64M |
| Short-Term Investments | $92.21M | $0 | -- |
| **Cash & Short-Term Investments** | $281.1M | $354.3M | $21.64M |
| Accounts Receivable, Net | $769K | $0 | -- |
| **Total Current Assets** | $286.8M | $357.1M | $25.31M |
| Property, Plant & Equipment, Net | $963K | $591K | $323K |
| Long-Term Investments | $100K | $100K | $100K |
| Other Non-Current Assets | $316K | $240K | -- |
| **Total Non-Current Assets** | $8.10M | $1.13M | $618K |
| **Total Assets** | $294.9M | $358.2M | $25.92M |
| Accounts Payable | $2.67M | $2.00M | $1.87M |
| Short-Term Debt | $2.65M | $6.00M | $6.00M |
| Deferred Revenue (Current) | $5.75M | $7.83M | -- |
| **Total Current Liabilities** | $20.14M | $27.77M | $58.17M |
| Long-Term Debt | $0 | $2.50M | $8.20M |
| Deferred Revenue (Non-Current) | $0 | $4.67M | -- |
| **Total Non-Current Liabilities** | $2.70M | $7.33M | $8.43M |
| **Total Liabilities** | $22.84M | $35.11M | $66.60M |
| **Total Debt (incl. Leases)** | $5.56M | $8.70M | $14.39M |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$333.4M | -$252.8M | -$181.7M |
| Accumulated Other Comp. Income | $278K | $245K | $164K |
| **Total Stockholders' Equity** | $272.1M | $323.1M | -$173.4M |
| Total Equity | $272.1M | $323.1M | -$173.4M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $52.67M | $73.96M | $241.8M | $188.9M | $215.6M | $220.3M | $257.5M | $354.3M |
| Short-Term Investments | $231.0M | $244.8M | $141.4M | $92.21M | $70.20M | $76.97M | $63.03M | $0 |
| **Cash & Short-Term Investments** | $283.6M | $318.7M | $383.2M | $281.1M | $285.8M | $297.3M | $320.5M | $354.3M |
| Accounts Receivable, Net | $565K | $625K | $709K | $769K | $515K | $603K | $361K | $0 |
| **Total Current Assets** | $295.1M | $330.3M | $391.9M | $286.8M | $290.8M | $301.7M | $324.8M | $357.1M |
| Property, Plant & Equipment, Net | $1.13M | $1.21M | $1.11M | $963K | $973K | $974K | $929K | $591K |
| Long-Term Investments | $68.70M | $100K | $100K | $100K | $100K | $100K | $100K | $100K |
| Other Non-Current Assets | $305K | $208K | $215K | $316K | $227K | $237K | $239K | $240K |
| **Total Non-Current Assets** | $72.59M | $66.62M | $5.79M | $8.10M | $14.26M | $20.45M | $19.03M | $1.13M |
| **Total Assets** | $367.6M | $396.9M | $397.7M | $294.9M | $305.1M | $322.1M | $343.8M | $358.2M |
| Accounts Payable | $1.89M | $5.65M | $3.07M | $2.67M | $5.02M | $1.33M | $3.99M | $2.00M |
| Short-Term Debt | $0 | $0 | $1.16M | $2.65M | $4.13M | $5.60M | $6.00M | $6.00M |
| Deferred Revenue (Current) | $4.63M | $4.36M | $6.19M | $5.75M | $7.51M | $7.70M | $8.18M | $7.83M |
| **Total Current Liabilities** | $19.03M | $19.22M | $15.83M | $20.14M | $24.49M | $22.84M | $23.74M | $27.77M |
| Long-Term Debt | -- | -- | -- | $0 | $0 | $0 | $1.06M | $2.50M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $556K | $1.90M | $3.23M | $4.67M |
| **Total Non-Current Liabilities** | $2.17M | $2.80M | $2.71M | $2.70M | $3.13M | $4.53M | $6.94M | $7.33M |
| **Total Liabilities** | $21.20M | $22.02M | $18.53M | $22.84M | $27.63M | $27.37M | $30.67M | $35.11M |
| **Total Debt (incl. Leases)** | $2.73M | $2.83M | $4.03M | $5.56M | $7.13M | $8.75M | $10.31M | $8.70M |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | -- | $0 |
| Retained Earnings | -$415.3M | -$381.8M | -$355.7M | -$333.4M | -$307.5M | -$287.3M | -$265.7M | -$252.8M |
| Accumulated Other Comp. Income | -$1.17M | -$478K | $73K | $278K | $275K | $212K | $264K | $245K |
| **Total Stockholders' Equity** | $346.4M | $374.9M | $379.1M | $272.1M | $277.5M | $294.8M | $313.2M | $323.1M |
| Total Equity | $346.4M | $374.9M | $379.1M | $272.1M | $277.5M | $294.8M | $313.2M | $323.1M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$80.61M | -$71.11M | -$63.85M |
| Depreciation & Amortization | $200K | $200K | $200K |
| Stock-Based Compensation | $11.69M | $6.98M | $3.02M |
| Change in Receivables | -$769K | $0 | -- |
| Change in Payables | $788K | $6.0K | -$393K |
| **Operating Cash Flow** | -$81.63M | -$51.52M | -$37.36M |
| Capital Expenditure | -$719K | -$366K | -$166K |
| **Free Cash Flow** | -$82.35M | -$51.89M | -$37.53M |
| Purchases of Investments | -$154.7M | $0 | -- |
| **Investing Cash Flow** | -$95.22M | -$366K | -$266K |
| Common Stock Issued | $17.16M | $0 | -- |
| **Financing Cash Flow** | $11.47M | $381.2M | $34.94M |
| **Net Change in Cash** | -$165.5M | $329.4M | -$2.69M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$33.50M | -$26.10M | -$22.25M | -$25.94M | -$20.17M | -$21.56M | -$12.93M | -$21.13M |
| Stock-Based Compensation | $4.64M | $4.27M | $4.26M | $2.72M | $2.79M | $3.23M | $2.95M | $2.72M |
| Change in Receivables | $60K | $84K | $60K | -$254K | $88K | -$242K | -$361K | $0 |
| Change in Payables | -$3.67M | $2.58M | $326K | -$2.31M | $3.65M | -$2.60M | $2.05M | -$126K |
| **Operating Cash Flow** | -$30.96M | -$19.26M | -$24.05M | -$28.25M | -$16.04M | -$19.97M | -$17.36M | -$5.14M |
| Capital Expenditure | -$18K | -$328K | -$26K | -$112K | -$22K | -$159K | -$426K | -$26K |
| **Free Cash Flow** | -$30.98M | -$19.59M | -$24.07M | -$28.36M | -$16.07M | -$20.13M | -$17.79M | -$5.16M |
| Purchases of Investments | -$60.87M | -$203.8M | -$80.21M | -$40.32M | -$12.89M | -$23.98M | -$77.56M | $0 |
| **Investing Cash Flow** | $7.54M | -$164.5M | -$46.75M | -$14.43M | $12.84M | -$15.64M | -$77.99M | -$26K |
| **Financing Cash Flow** | $2.08M | $15.97M | $123.7M | $16.01M | -$1.54M | -$1.50M | -$1.50M | $24.90M |
| **Net Change in Cash** | -$21.30M | -$167.8M | $52.89M | -$26.68M | -$4.76M | -$37.16M | -$96.86M | $19.88M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Operating Margin** | -1031.5% | -- | -- |
| **Net Profit Margin** | -896.1% | -- | -- |
| Return on Equity (ROE) | -29.6% | -22.0% | -- |
| Return on Assets (ROA) | -27.3% | -19.8% | -246.3% |
| Current Ratio | 14.24x | 12.86x | 0.44x |
| Quick Ratio | 14.00x | 12.76x | 0.37x |
| Debt to Equity | 0.02x | 0.03x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1401.8% | -1026.3% | -985.9% | -1031.5% | -- | -- | -- | -- |
| **Net Profit Margin** | -1253.6% | -912.3% | -871.8% | -896.1% | -- | -- | -- | -- |
| Return on Equity (ROE) | -31.1% | -25.2% | -23.7% | -29.6% | -27.3% | -26.8% | -22.7% | -22.0% |
| Return on Assets (ROA) | -29.3% | -23.8% | -22.6% | -27.3% | -24.8% | -24.5% | -20.7% | -19.8% |
| Current Ratio | 15.51x | 17.19x | 24.76x | 14.24x | 11.87x | 13.21x | 13.68x | 12.86x |
| Quick Ratio | 14.94x | 16.62x | 24.26x | 14.00x | 11.69x | 13.04x | 13.52x | 12.76x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.02x | 0.03x | 0.03x | 0.03x | 0.03x |
| **Revenue Growth (YoY)** | -85.5% | +1.6% | +91.0% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
